Literature DB >> 3977783

Multifrequency tympanometry in normal ears.

R H Margolis, K J Van Camp, R H Wilson, W L Creten.   

Abstract

Susceptance and conductance tympanograms were recorded from 10 normal subjects with probe frequencies ranging from 220 to 910 Hz. Tympanometric shapes progressed through an orderly sequence of patterns, becoming more complex with increasing probe frequency. When the direction of ear-canal air pressure change was from negative to positive values, more complicated tympanometric shapes occurred for all subjects, compared to the positive to negative direction. The results are discussed in relation to the Vanhuyse et al. [Scand. Audiol. 4:45-50, 1975] model of tympanometric shapes. In general, the model is a good first approximation to the distribution of tympanometric patterns from normal ears.

Mesh:

Year:  1985        PMID: 3977783     DOI: 10.3109/00206098509070096

Source DB:  PubMed          Journal:  Audiology        ISSN: 0020-6091


  4 in total

1.  Auditory function and hearing loss in children and adults with Williams syndrome: cochlear impairment in individuals with otherwise normal hearing.

Authors:  Jeffrey A Marler; Jessica L Sitcovsky; Carolyn B Mervis; Doris J Kistler; Frederic L Wightman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-05-15       Impact factor: 3.908

2.  Efficacy of Multicomponent Tympanometry in Identifying Middle Ear Disorder.

Authors:  Mrudul Raut; C S Vanaja
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-01-04

3.  Can Wideband Absorbance Be Used in the Detection of Ossicular Chain Defects?

Authors:  Fulya Savran Turanoglu; Ozan Ozdemir; Cigdem Kalaycik Ertugay; Ozgur Yigit
Journal:  Iran J Otorhinolaryngol       Date:  2022-09

4.  Can Wideband Tympanometry Be Used as a Screening Test for Superior Semicircular Canal Dehiscence?

Authors:  Emine Demir; Nazife Nur Afacan; Metin Celiker; Fatma Beyazal Celiker; Mehmet Fatih İnecikli; Suat Terzi; Engin Dursun
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-11-22       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.